By 2030, the market is expected to reach a value between USD 130and 450 billion, reflecting the following key drivers:
Ongoing legalization efforts across North America, Europe, LATAM and parts of Africa and Asia.
Medical demand for chronic pain, neurological conditions, oncology support and palliative care.
Consumer shift from alcohol and pharmaceuticals toward natural, plant-based alternatives
Industrial and wellness expansion, including cosmetics, functional foods, and nutraceuticals
Institutional capital entering the space, legitimizing cannabis as an asset class.
“The ultimate goal of farming is not the growing of crops, but the cultivation of human beings.”
Masanobu Fukuoka
The Roots of Our Success
Our farm blends science-driven cultivation with sustainable practices to deliver consistent, high-quality medical-grade cannabis for patients worldwide.
- Precision-Grown Strains for Therapeutic Use
- Clean, Controlled, and Fully Traceable Production



The cannabis plant has a long history of medicinal use across different cultures worldwide. Swiss Global Agriculture Limited is committed to integrating the East African region into the expanding global hemp and cannabis market, contributing to a sector that is experiencing significant growth in more developed markets.
.
“The ultimate goal of farming is not the growing of crops, but the cultivation of human beings.”
Masanobu Fukuoka